GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.
Kuang R, Jahangiri A, Mascharak S, Nguyen A, Chandra A, Flanigan PM, Yagnik G, Wagner JR, De Lay M, Carrera D, Castro BA, Hayes J, Sidorov M, Garcia JLI, Eriksson P, Ronen S, Phillips J, Molinaro A, Koliwad S, Aghi MK.
Kuang R, et al. Among authors: eriksson p.
JCI Insight. 2017 Jan 26;2(2):e88815. doi: 10.1172/jci.insight.88815.
JCI Insight. 2017.
PMID: 28138554
Free PMC article.